Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin-angiotensin system

Journal of Hypertension

Volumn 34, Issue 9, 2016, Pages 1752-1765

  Clotet, Sergi ^a   Soler, María José ^a,c   Rebull, Marta ^a   Gimeno, Javier ^a   Gurley, Susan B ^b   Pascual, Julio ^a,c   Riera, Marta ^a,c  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b DUKE UNIVERSITY   (United States)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

blood pressure; diabetic nephropathy; gonadectomy; renin angiotensin system; streptozotocin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN CONVERTING ENZYME 2; COLLAGEN; PROTEIN KINASE B; STREPTOZOCIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME PHOSPHORYLATION; EXPERIMENTAL DIABETIC NEPHROPATHY; GENE EXPRESSION; GENE INACTIVATION; GONADECTOMY; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; BLOOD PRESSURE; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; KNOCKOUT MOUSE; METABOLISM; ORCHIECTOMY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY GLOMERULUS; MALE; MICE; MICE, KNOCKOUT; ORCHIECTOMY; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM;

EID: 84977160991     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001015     Document Type: Article

References (54)

1. CrackowerMA, SaraoR,OuditGY,Yagil C,Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417:822-828.
2. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R, et al. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 2006; 168:1808-1820.
3. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH, et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 2007; 75:29-39.
4. Averill DB, Ishiyama Y, Chappell MC, Ferrario CM. Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. Circulation 2003; 108:2141-2146.
5. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17:3067-3075.
6. Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, Batlle D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 2007; 72:614-623.
7. Soler MJ, Barrios C, Oliva R, Batlle D. Pharmacologic modulation of ACE2 expression. Curr Hypertens Rep 2008; 10:410-414.
8. Shiota A, Yamamoto K, Ohishi M, Tatara Y, Ohnishi M, Maekawa Y, et al. Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. Hypertens Res 2010; 33:298-307.
9. Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis 2013; 20:390-395.
10. Icks A, Haastert B, Genz J, Giani G, Hoffmann F, Trapp R, et al. Incidence of renal replacement therapy (RRT) in the diabetic compared with the nondiabetic population in a German region, 2002-08. Nephrol Dial Transplant 2011; 26:264-269.
11. Metcalfe PD, Meldrum KK. Sex differences and the role of sex steroids in renal injury. J Urol 2006; 176:15-21.
12. Anguiano L, Riera M, Pascual J, Valdivielso JM, Barrios C, Betriu A, et al. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease. Nephrol Dial Transplant 2015; 30:1176-1185.
13. Liu J, Ji H, Zheng W, Wu X, Zhu JJ, Arnold AP, et al. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17boestradiol-dependent and sex chromosome-independent. Biol Sex Differ 2010; 1:6.
14. Ji H, Menini S, Zheng W, Pesce C, Wu X, Sandberg K. Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17b-oestradiol regulation of renal pathology in renal wrap hypertension in rats. Exp Physiol 2008; 93:648-657.
15. Yamaleyeva LM, Gilliam-Davis S, Almeida I, Brosnihan KB, Lindsey SH, Chappell MC. Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2. Lewis rats with early-onset diabetes. Am J Physiol Renal Physiol 2012; 302:F1374-F1384.
16. Clotet S, Riera M, Pascual J, Soler MJ. RAS and sex differences in diabetic nephropathy. Am J Physiol Renal Physiol 2016; 310:F945-F957.
17. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 2006; 116:2218-2225.
18. Riera M, Anguiano L, Clotet S, Roca-Ho H, Rebull M, Pascual J, et al. Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria. Am J Physiol Renal Physiol 2016; 310:F534-F546.
19. Riera M, Marquez E, Clotet S, Gimeno J, Roca-Ho H, Lloreta J, et al. Effect of insulin on ACE2 activity and kidney function in the nonobese diabetic mouse. PLoS One 2014; 9:e84683.
20. Nadarajah R, Milagres R, Dilauro M, Gutsol A, Xiao F, Zimpelmann J, et al. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int 2012; 82:292-303.
21. Schwager SL, Carmona AK, Sturrock ED. A high-throughput fluorimetric assay for angiotensin I-converting enzyme. Nat Protoc 2006; 1:1961-1964.
22. Marquez E, Riera M, Pascual J, Soler MJ. Albumin inhibits the insulinmediated ACE2 increase in cultured podocytes. Am J Physiol Renal Physiol 2014; 306:F1327-F1334.
23. Flaquer M, Franquesa M, Vidal A, Bolanos N, Torras J, Lloberas N, et al. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 2012; 55:2059-2068.
24. Grimm PC, Nickerson P, Gough J, McKenna R, Stern E, Jeffery J, et al. Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 2003; 14:1662-1668.
25. Tikellis C, Bialkowski K, Pete J, Sheehy K, Su Q, Johnston C, et al. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008; 57:1018-1025.
26. Tikellis C, Brown R, Head GA, Cooper ME, Thomas MC. Angiotensinconverting enzyme 2 mediates hyperfiltration associated with diabetes. Am J Physiol Renal Physiol 2014; 306:F773-F780.
27. Ehlers MR, Schwager SL, Scholle RR, Manji GA, Brandt WF, Riordan JF. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence. Biochemistry 1996; 35:9549-9559.
28. Allinson TM, Parkin ET, Condon TP, Schwager SL, Sturrock ED, Turner AJ, et al. The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein. Eur J Biochem 2004; 271:2539-2547.
29. Salem ES, Grobe N, Elased KM. Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice. Am J Physiol Renal Physiol 2014; 306:F629-F639.
30. Huang SM, Chang YH, Chao YC, Lin JA, Wu CH, Lai CY, et al. EGCGrich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes. Mol Nutr Food Res 2013; 57:2264-2268.
31. Abeyrathna P, Su Y. The critical role of Akt in cardiovascular function. Vascul Pharmacol 2015; 74:38-48.
32. Xiao F, Zimpelmann J, Agaybi S, Gurley SB, Puente L, Burns KD. Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells. PLoS One 2014; 9:e85958.
33. Lim YK, Retnam L, Bhagavath B, Sethi SK, bin Ali A, Lim SK. Gonadal effects on plasma ACE activity in mice. Atherosclerosis 2002; 160:311-316.
34. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, Diz DI, et al. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 2007; 292:F82-91.
35. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007; 171:438-451.
36. Liu Z, Huang XR, Chen HY, Penninger JM, Lan HY. Loss of angiotensinconverting enzyme 2 enhances TGF-b/Smad-mediated renal fibrosis and NF-kB-driven renal inflammation in a mouse model of obstructive nephropathy. Lab Invest 2012; 92:650-661.
37. Wang W, Koka V, Lan HY. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005; 10:48-56.
38. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006; 21:16-20.
39. Sanchez-Lopez E, Rodriguez-Vita J, Cartier C, Ruperez M, Esteban V, Carvajal G, et al. Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Am J Physiol Renal Physiol 2008; 294:F149-F160.
40. Hua P, FengW, RezonzewG, Chumley P, Jaimes EA. The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cells. Am J Physiol Renal Physiol 2012; 302:F1418-F1429.
41. Lan A, Du J. Potential role of Akt signaling in chronic kidney disease. Nephrol Dial Transplant 2015; 30:385-394.
42. Mavroeidi V, Petrakis I, Stylianou K, Katsarou T, Giannakakis K, Perakis K, et al. Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy. J Histochem Cytochem 2013; 61:433-443.
43. Shemesh II, Rozen-Zvi B, Kalechman Y, Gafter U, Sredni B. AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway. PLoS One 2014; 9:e114287.
44. Bai X, Li X, Tian J, Zhou Z. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes. PLoS One 2014; 9:e96117.
45. Wu SZ, Peng FF, Li JL, Ye F, Lei SQ, Zhang BF. Akt and RhoA activation in response to high glucose require caveolin-1 phosphorylation in mesangial cells. Am J Physiol Renal Physiol 2014; 306:F1308-F1317.
46. Sun L, Li W, Xiong L, Li G, Ma R. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ ROS/Akt/NF-kB pathway under high glucose conditions. Int J Mol Med 2014; 34:167-176.
47. Rodriguez-Pena AB, Fuentes-Calvo I, Docherty NG, Arevalo M, Grande MT, Eleno N, et al. Effect of angiotensin II and small GTPase Ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy. Biomed Res Int 2014; 2014:124902.
48. Morales MG, Abrigo J, Acuna MJ, Santos RA, Bader M, Brandan E, et al. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy via the Mas receptor. Dis Model Mech 2016; 9:441-449.
49. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 2003; 285:F219-F229.
50. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007; 49:185-192.
51. White JP, Gao S, Puppa MJ, Sato S, Welle SL, Carson JA. Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle. Mol Cell Endocrinol 2013; 365:174-186.
52. Yu Y, Zhang Y, Guan W, Huang T, Kang J, Sheng X, et al. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation. Mol Cancer Res 2014; 12:830-842.
53. Zhang BG, Du T, Zang MD, Chang Q, Fan ZY, Li JF, et al. Androgen receptor promotes gastric cancer cell migration and invasion via AKTphosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget 2014; 5:10584-10595.
54. Xu Q, Wells CC, Garman JH, Asico L, Escano CS, Maric C. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension 2008; 51:1218-1224.